• Users Online: 43949
  • Home
  • Print this page
  • Email this page

    Article Cited by others

LETTER TO EDITOR

Role of intravitreal triamcinolone as an adjuvant in the management of Vogt-Koyanagi-Harada disease

Moreker Mayur R, Lodhi Sikander A, Pathengay Avinash

Year : 2007| Volume: 55| Issue : 6 | Page no: 479-480

   This article has been cited by
 
1 Suprachoroidal triamcinolone acetonide injection: a novel therapy for serous retinal detachment due to Vogt-Koyanagi Harada disease
Ahmed Abdelshafy Tabl, Mohamed Anany Elsayed, Marwa Abdelshafy Tabl
European Journal of Ophthalmology. 2022; : 1120672122
[Pubmed]  [Google Scholar] [DOI]
2 Uveitis Therapy: The Corticosteroid Options
Lianna M. Valdes, Lucia Sobrin
Drugs. 2020; 80(8): 765
[Pubmed]  [Google Scholar] [DOI]
3 Allergy against Steroids in Ocular Inflammation
Luz Elena Concha-Del Rio, Pilar Uribe-Reina, Alejandra De-La-Torre
Ocular Immunology and Inflammation. 2020; : 1
[Pubmed]  [Google Scholar] [DOI]
4 Sustained Release Corticosteroid Therapy for Noninfectious Uveitis
Durga S. Borkar, Cindy Ung, Lucia Sobrin
International Ophthalmology Clinics. 2017; 57(4): 193
[Pubmed]  [Google Scholar] [DOI]
5 Think Global ? Act Local: Intravitreal Drug Delivery Systems in Chronic Noninfectious Uveitis
Dicle Hazirolan,Uwe Pleyer
Ophthalmic Research. 2013; 49(2): 59
[Pubmed]  [Google Scholar] [DOI]
6 Vogt-Koyanagi-Harada Disease in the Developing World :
Luz Elena Concha del Río, Lourdes Arellanes-García
International Ophthalmology Clinics. 2010; 50(2): 189-199
[Pubmed]  [Google Scholar] [DOI]
7 Intravitreal triamcinolone for intraocular inflammation and associated macular edema
Couch, S.M. and Bakri, S.J.
Clinical Ophthalmology. 2009; 3: 41-47
[Pubmed]  [Google Scholar]

 

Read this article